141
Views
20
CrossRef citations to date
0
Altmetric
Review

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions

&
Pages 2253-2262 | Published online: 24 Nov 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fabrizia D’Antonio, Antonella Di Vita, Giulia Zazzaro, Marco Canevelli, Alessandro Trebbastoni, Alessandra Campanelli, Stefano Ferracuti, Carlo de Lena, Cecilia Guariglia & Maddalena Boccia. (2022) Cortical complexity alterations in the medial temporal lobe are associated with Alzheimer’s disease psychosis. Aging, Neuropsychology, and Cognition 29:6, pages 1022-1032.
Read now

Articles from other publishers (19)

Saikat Pal, Rituparna Roy & Sandip Paul. (2022) Deciphering the Role of ATP on PHF6 Aggregation. The Journal of Physical Chemistry B 126:26, pages 4761-4775.
Crossref
J. J. Gomar, G. Tan, J. Halpern, M. L. Gordon, B. Greenwald & J. Koppel. (2022) Increased retention of tau PET ligand [18F]-AV1451 in Alzheimer’s Disease Psychosis. Translational Psychiatry 12:1.
Crossref
Heidy Jimenez, Leslie Adrien, Adam Wolin, John Eun, Eric H. Chang, Ethan S. Burstein, Jesus Gomar, Peter Davies & Jeremy Koppel. (2022) The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT– and rTg(P301L)4510 mouse models of Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions 8:1.
Crossref
Karolina Maciejewska, Kamila Czarnecka & Paweł Szymański. (2021) A review of the mechanisms underlying selected comorbidities in Alzheimer’s disease. Pharmacological Reports 73:6, pages 1565-1581.
Crossref
Ismaeel Yunusa, Marie Line El Helou & Saud Alsahali. (2020) Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related Psychosis. Frontiers in Pharmacology 11.
Crossref
Nan Cai, Jiajie Chen, Decheng Bi, Liang Gu, Lijun Yao, Xiuting Li, Hui Li, Hong Xu, Zhangli Hu, Qiong Liu & Xu Xu. (2020) Specific Degradation of Endogenous Tau Protein and Inhibition of Tau Fibrillation by Tanshinone IIA through the Ubiquitin–Proteasome Pathway. Journal of Agricultural and Food Chemistry 68:7, pages 2054-2062.
Crossref
Hacı Ömer Yilmaz, Nurcan Yabanci Ayhan & Çağdaş Salih Meriç. (2020) Buckwheat: A Useful Food and Its Effects on Human Health. Current Nutrition & Food Science 16:1, pages 29-34.
Crossref
Chirag M. Vyas & Olivia I. Okereke. (2019) Vitamin D and Psychosis in Alzheimer Disease: New Insights From Pharmacogenomics Research. The American Journal of Geriatric Psychiatry 27:9, pages 918-919.
Crossref
Fabrizia D'Antonio, Suzanne Reeves, Yucheng Sheng, Emma McLachlan, Carlo Lena, Robert Howard & Julie Bertrand. (2019) Misidentification Subtype of Alzheimer's Disease Psychosis Predicts a Faster Cognitive Decline. CPT: Pharmacometrics & Systems Pharmacology 8:5, pages 308-315.
Crossref
Lies Van Assche, Evelyne Van Aubel, Lucas Van de Ven, Filip Bouckaert, Patrick Luyten & Mathieu Vandenbulcke. (2019) The Neuropsychological Profile and Phenomenology of Late Onset Psychosis: A Cross-sectional Study on the Differential Diagnosis of Very-Late-Onset Schizophrenia-Like Psychosis, Dementia with Lewy Bodies and Alzheimer’s Type Dementia with Psychosis. Archives of Clinical Neuropsychology 34:2, pages 183-199.
Crossref
Jeremy Koppel, Heidy Jimenez, Leslie Adrien, Eric H. Chang, Anil K. Malhotra & Peter Davies. (2019) Increased tau phosphorylation follows impeded dopamine clearance in a P301L and novel P301L/COMT-deleted (DM) tau mouse model. Journal of Neurochemistry 148:1, pages 127-135.
Crossref
Luisa Fernanda Ahunca Velásquez. (2017) Más allá del deterioro cognitivo: síntomas neuropsiquiátricos en demencias neurodegenerativas. Revista Colombiana de Psiquiatría 46, pages 51-58.
Crossref
Lyssandra dos Santos Tascone, Martha E. Payne, James MacFall, Dionísio Azevedo, Claudio Campi de Castro, David C. Steffens, Geraldo F. Busatto & Cássio M. C. Bottino. (2017) Cortical brain volume abnormalities associated with few or multiple neuropsychiatric symptoms in Alzheimer’s disease. PLOS ONE 12:5, pages e0177169.
Crossref
Michael W. Weiner, Dallas P. Veitch, Paul S. Aisen, Laurel A. Beckett, Nigel J. Cairns, Robert C. Green, Danielle Harvey, Clifford R. JackJr.Jr., William Jagust, John C. Morris, Ronald C. Petersen, Andrew J. Saykin, Leslie M. Shaw, Arthur W. Toga & John Q. Trojanowski. (2017) Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. Alzheimer's & Dementia 13:4.
Crossref
Zhi-yong Wang, Jian-gang Liu, Yun Wei, Mei-xia Liu, Qi Wang, Lin Liang, Hui-min Yang & Hao Li. (2017) Huannao Yicong Formula (还脑益聪方) regulates γ-secretase activity through APH-1 and PEN-2 gene ragulation pathways in hippocampus of APP/PS1 double transgenic mice. Chinese Journal of Integrative Medicine 23:4, pages 270-278.
Crossref
Jeremy Koppel, Heidy Jimenez, Leslie Adrien, Blaine S. Greenwald, Philippe Marambaud, Ezra Cinamon & Peter Davies. (2016) Haloperidol inactivates AMPK and reduces tau phosphorylation in a tau mouse model of Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions 2:2, pages 121-130.
Crossref
Zhi-Yong Wang, Jian-Gang Liu, Hao Li & Hui-Ming Yang. (2016) Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review. The American Journal of Chinese Medicine 44:08, pages 1525-1541.
Crossref
Aaron M. Koenig, Steven E. Arnold & Joel E. Streim. (2015) Agitation and Irritability in Alzheimer’s Disease: Evidenced-Based Treatments and the Black-Box Warning. Current Psychiatry Reports 18:1.
Crossref
Juan Antonio Giménez-Bastida & Henryk Zieliński. (2015) Buckwheat as a Functional Food and Its Effects on Health. Journal of Agricultural and Food Chemistry 63:36, pages 7896-7913.
Crossref